Vertex Sits On $1.4bn Cash, Seeks External Innovation Away From CF

 
• By Lucie Ellis-Taitt
  
Dollar sign
Vertex has the cash to pursue new opportunies outside of cystic fibrosis • Source: Shutterstock

More from Strategy

More from Business